The Leadership Team at Iovance Biotherapeutics is responsible for guiding the strategic direction and operational oversight of the company as it develops innovative T cell-based therapies for cancer treatment. This diverse group of executives collaborates across various functions, including research, quality, operations, and commercial strategy, to ensure alignment with Iovance's mission of improving patient care and advancing cutting-edge cancer therapies. Through their collective expertise, the Leadership Team drives decision-making, fosters a culture of innovation, and builds partnerships essential for the company’s success in the biotherapeutics industry.
Brian Shew
SVP, Head of Digital & Informa...
Frederick G. Vogt
Interim CEO, President & Gener...
Friedrich Graf Finck...
Chief Medical Officer
Hequn Yin
SVP, Research
Howard B. Johnson
Chief Business Officer
Igor Bilinsky
COO
Jean-Marc Bellemin
CFO
Kevin Smyth
EVP, Quality
Raj K. Puri
EVP, Regulatory Strategy & Tra...
Tracy Winton
EVP, Human Resources
View all